joyce o’shaughnessy, md: candidacy for eribulin therapy
Published 8 years ago • 72 plays • Length 1:11
Download video MP4
Download video MP3
Similar videos
-
1:11
joyce o’shaughnessy, md: candidacy for eribulin therapy
-
1:20
dr. o’shaughnessy on eribulin as first-line therapy for metastatic her2-negative breast cancer
-
0:59
joyce o’shaughnessy, md: main indications for dose reduction with eribulin
-
1:39
joyce o’shaughnessy, md: efficacy data supporting the use of eribulin mesylate
-
1:23
joyce o’shaughnessy, md: different mechanisms of action in eribulin
-
2:08
dr. joyce o'shaughnessy on eribulin in metastatic breast cancer
-
1:47
dr. joyce o'shaughnessy on treatment with everolimus in advanced breast cancer
-
1:20
joyce o’shaughnessy, md: fourth-line considerations in metastatic tnbc
-
1:03:21
nbe- journal club- landmark recent papers in breast cancer- dr. saumyta, dr. svs deo, dr. rosina
-
16:01
what is inflammatory breast cancer? patient jennifer cordts talks with dr. joyce o’shaughnessy
-
51:57
breaking news: updates from the 2024 asco annual meeting
-
0:53
joyce o’shaughnessy, md: principle third-line options for patients with metastatic tnbc
-
2:04
dr. joyce o’shaughnessy on promising agents in triple-negative breast cancer
-
1:20
joyce o’shaughnessy, md: fourth-line considerations
-
25:35
dr. joyce o'shaughnessy (breast oncologist) - interview from drummathon 2020
-
0:58
joyce o’shaughnessy, md: third-line options available to prolong life in tnbc
-
1:28
joyce o’shaughnessy, md, on differentiating cdk4/6 inhibitors
-
1:56
joyce o’shaughnessy, md: treatment goals for patients with tnbc
-
1:56
joyce o’shaughnessy, md: treatment goals for patients with tnbc and multiple metastatic sites
-
0:56
joyce o'shaughnessy, md explains the importance of the school of breast oncology
-
1:09
joyce o’shaughnessy, md, shares results of the impassion130 trial presented at esmo 2019
-
7:28
patient success stories: her2 metastatic breast cancer, joyce o’shaughnessy md
Clip.africa.com - Privacy-policy